Boditech Med Inc. (KOSDAQ:206640)

South Korea · Delayed Price · Currency is KRW

10,080

-50 (-0.49%)

Sep 1, 2026, 3:30 PM KST

-30.15% (1Y)

Market Cap	206.09B -34.4%
Revenue (ttm)	174.78B +15.0%
Net Income	25.95B -6.7%
EPS	1,200.16 -5.6%
Shares Out	20.34M
PE Ratio	8.44
Forward PE	n/a
Dividend	150.00 (1.44%)
Ex-Dividend Date	Mar 31, 2026

Volume	16,902
Open	10,140
Previous Close	10,130
Day's Range	10,000 - 10,150
52-Week Range	9,580 - 15,000
Beta	0.37
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2026

About Boditech Med

Boditech Med Inc. offers instruments and diagnostic reagents in South Korea and internationally. The company offers instruments, including ichroma II, diagnostic immuno-analyzer to measure the presence of various biomarkers for cardiac, cancer, hormones, infectious diseases, autoimmune diseases, and metabolic diseases; ichroma III, a high-throughput immuno-analyzer that enables simultaneous testing for various parameters; ExAmplar, a compact real time PCR that detects virus/bacteria quantitatively or qualitatively using ready-to-use cartridges;... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 1998

Employees 541

Stock Exchange KOSDAQ

Ticker Symbol 206640

Full Company Profile

Financial Performance

In 2025, Boditech Med's revenue was 162.09 billion, an increase of 17.32% compared to the previous year's 138.16 billion. Earnings were 23.65 billion, a decrease of -13.23%.

Financial Statements